반응식
[CH:1]([C:4]1[CH:9]=[CH:8][CH:7]=[CH:6][C:5]=1[NH:10][C:11]1[NH:12][C:13]2[CH:19]=[C:18]([C:20](O)=[O:21])[CH:17]=[CH:16][C:14]=2[N:15]=1)([CH3:3])[CH3:2].[NH2:23][C:24]1[CH:32]=[C:31]2[C:27]([C:28]([NH:33][C:34]([CH:36]3[CH2:41][CH2:40][N:39]([CH3:42])[CH2:38][CH2:37]3)=[O:35])=[N:29][NH:30]2)=[CH:26][CH:25]=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>>[CH3:42][N:39]1[CH2:38][CH2:37][CH:36]([C:34]([NH:33][C:28]2[C:27]3[C:31](=[CH:32][C:24]([NH:23][C:20]([C:18]4[CH:17]=[CH:16][C:14]5[N:15]=[C:11]([NH:10][C:5]6[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=6[CH:1]([CH3:2])[CH3:3])[NH:12][C:13]=5[CH:19]=4)=[O:21])=[CH:25][CH:26]=3)[NH:30][N:29]=2)=[O:35])[CH2:41][CH2:40]1참가 물질
4
반응물 3
생성물 1
실험 절차
2-(2-Isopropylphenylamino)-3H-benzimidazole-5-carboxylic acid (0.3 mmol; see Example 66) was coupled with aforementioned 1-methylpiperidine-4-carboxylic acid (6-amino-1H-indazol-3-yl)-amide (0.3 mmol) using HBTU as described in general procedure D to afford the desired product, 2-(2-Isopropylphenylamino)-3H-benzimidazole-5-carboxylic acid {3-[(1-methylpiperidine-4-carbonyl)-amino]-1H-indazol-6-yl}-amide. MS: m/z 551 (M+H)+.
출처 및 근거
- ORD 기록
- ord-4f58f898bff34badb12f0e75fa7a75c8
- 출처 데이터셋
- uspto-grants-2013_02
- 특허 번호
- US08377983B2
연결된 노트
불러오는 중…